APA (7th ed.) Citation

ML, O. M., CA, R., E, d. J., SM, L., YCG, L., RM, Z., . . . WJ, L. (2023). Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma. PloS one, 18(5), e0274364. https://doi.org/10.1371/journal.pone.0274364

Chicago Style (17th ed.) Citation

ML, Orozco Morales, Rinaldi CA, de Jong E, Lansley SM, Lee YCG, Zemek RM, Bosco A, Lake RA, and Lesterhuis WJ. "Geldanamycin Treatment Does Not Result in Anti-cancer Activity in a Preclinical Model of Orthotopic Mesothelioma." PloS One 18, no. 5 (2023): e0274364. https://doi.org/10.1371/journal.pone.0274364.

MLA (9th ed.) Citation

ML, Orozco Morales, et al. "Geldanamycin Treatment Does Not Result in Anti-cancer Activity in a Preclinical Model of Orthotopic Mesothelioma." PloS One, vol. 18, no. 5, 2023, p. e0274364, https://doi.org/10.1371/journal.pone.0274364.